	Clinical Trial Access in Renal Cell Carcinoma: When Innovation Does Not Reach the Communities That Need It. JCO Oncol Pract Nandakumar V, Agarwal T, Gupta S, Swami U. PMID: 42809806 [PubMed - as supplied by publisher]
	Differential Diagnosis of ACTH-Dependent Hypercortisolism: Case Report and Literature Review. Rev Med Chil Oksenberg S, Nilo F, Villanueva P, Hernández MI, González C, Cruz JP, Baudrand R, Uslar T, Domínguez JM, Guarda FJ. PMID: 42809788 [PubMed - indexed for MEDLINE]
	The Association of Education and Unhealthy Lifestyles with Mortality Risk in the Chilean Population: A Prospective Analysis of the 2009-2010 National Health Survey. Rev Med Chil Ramírez-Alarcón K, Labraña AM, Martorell M, Villagrán-Cerro C, Parra-Soto S, Reyes-Molina D, Lanuza F, Concha-Cisternas Y, Díaz-Toro F, Petermann-Rocha F, Celis-Morales C, Carrasco-Marín F. PMID: 42809781 [PubMed - indexed for MEDLINE]
	A comparison of dermoscopic features of pigmented purpuric dermatoses and pigmented purpuric dermatosis-like mycosis fungoides. Acta Dermatovenerol Alp Pannonica Adriat Erol Mart HM, Keskin Z, Sanli H, Heper AO, Kirmizi A, Akay BN. PMID: 42809764 [PubMed - indexed for MEDLINE]
	Monocarboxylate Transporters (MCTs) in Physiology and Cancer: from Fundamentals to Clinical Translation. Physiol Rev Afonso J, Pereira-Vieira J, Miranda-Gonçalves V, Granja S, Pinheiro C, Baltazar F. PMID: 42809741 [PubMed - as supplied by publisher]
	Toward a Cure in Multiple Myeloma: Redefining Induction Therapy and the Role of Autologous Stem Cell Transplant. Cancer J Joshi A, Puliafito BR, Cirstea DD, Branagan AR, Gustine JN, Shome R, Panaroni C, Yee AJ, Raje NS. PMID: 42809701 [PubMed - indexed for MEDLINE]
	Tailoring Therapy for Frail and Elderly Myeloma Patients. Cancer J George T, Szalat RE. PMID: 42809700 [PubMed - indexed for MEDLINE]
	Managing Novel CAR T-Cell Toxicities in Multiple Myeloma. Cancer J Ang KK, Lipof J, Kumar A, Mikkilineni L, Chung A, Arora S, Sayre P, Wolf J, Chari A, Martin T, Pan D. PMID: 42809699 [PubMed - indexed for MEDLINE]
	T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity. Cancer J van de Donk NWCJ, Smits F, O'Neill C, Hoekman J, Kruyswijk S, Baglio SR, Zweegman S, Korst CLBM. PMID: 42809698 [PubMed - indexed for MEDLINE]
	CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma. Cancer J Sperling AS. PMID: 42809697 [PubMed - indexed for MEDLINE]
	Minimal Residual Disease (MRD) in Multiple Myeloma: From Prognostic Marker to Therapeutic Compass. Cancer J Tamariz-Amador LE, Rodriguez-Otero P, Manubens A, Lasa M, Gonzalez C, Paiva B, San-Miguel J. PMID: 42809696 [PubMed - indexed for MEDLINE]
	Monoclonal Antibodies and Antibody-Drug Conjugates: Expanding the Therapeutic Arsenal in Multiple Myeloma. Cancer J Ntanasis-Stathopoulos I, Terpos E, Dimopoulos MA. PMID: 42809695 [PubMed - indexed for MEDLINE]
	Proteostasis as a Therapeutic Backbone: Proteasome Inhibitors and Emerging Regimens. Cancer J Song Y, Theprungsirikul P, Gulla A, Anderson KC. PMID: 42809694 [PubMed - indexed for MEDLINE]
	Beyond Immunomodulatory Drugs: Next-Generation Cereblon Modulators in Multiple Myeloma. Cancer J Cani L, Mina R, Lonial S. PMID: 42809693 [PubMed - indexed for MEDLINE]
	Smoldering and Early Disease Interception. Cancer J Puertas B, Alejo E, Mateos MV. PMID: 42809692 [PubMed - indexed for MEDLINE]
	Risk Stratification in Myeloma: Defining Precision in the Genomic Era. Cancer J Schavgoulidze A, Corre J. PMID: 42809691 [PubMed - indexed for MEDLINE]
	Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial. J Clin Psychopharmacol Maekawa RM, Guerra LTL, Villanova B, de Paula CC, Zacharias ABV, Rodrigues LS, Reis JAS, Rossi GN, Bouso JC, Hallak JEC, Dos Santos RG. PMID: 42809662 [PubMed - as supplied by publisher]
	Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses. PLoS Med Chen PH, Dai MS, Huang MH, Chen HY, Kao LT, Hsieh TY, Jhou HJ, Lee CH. PMID: 42809593 [PubMed - as supplied by publisher]
	Efficacy and safety of T-DXd versus Other HER2-targeted therapies in second-line and later settings for HER2-positive metastatic breast cancer: A Bayesian network meta-analysis. PLoS One Xiao Y, Fu J, Li J, Hu G. PMID: 42809558 [PubMed - indexed for MEDLINE]
	Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation. PLoS One Chang L, Kang Y, Zhu M, Liu J, Lan C, Xu Q. PMID: 42809552 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1976700

Page 1 of 98835



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy